Ixico

About:

Ixico is a U.K.-based company that provides clinical trial services worldwide.

Website: http://www.ixico.com

Twitter/X: ixiconews

Top Investors: Innovate UK, octopus investments, Gresham House, SBRI Healthcare, Bram Goorden

Description:

Ixico is a U.K.-based company that provides clinical trial services worldwide. The company offers end-to-end imaging services in various therapeutic areas, primarily in the fields of oncology and neurology to the pharmaceutical industry, biotech companies, academia, and medical charities. Ixico offers technology developing solutions for the treatment of diseases, including predominantly dementia and other neuro degeneration diseases. It is based in London, England.

Total Funding Amount:

12.1M GBP

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

London, England, United Kingdom

Founded Date:

1995-01-01

Contact Email:

7032994611==info(AT)ixico.com

Founders:

Derek Hill

Number of Employees:

51-100

Last Funding Date:

2024-10-09

IPO Status:

Public

Industries:

© 2025 bioDAO.ai